Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05481138 · ClinicalTrials.gov registry record
Predicting Burnout in Nurses
A clinical trial of Burnout, Healthcare Workers, sponsored by Mayo Clinic.
- Completed
- Registry status
- 531
- Enrollment target
- 2
- Study locations
NCT05481138: Completed study of Burnout, Healthcare Workers, sponsored by Mayo Clinic.
NCT05481138 is a study of Burnout, Healthcare Workers that has completed, run by Mayo Clinic. The registered enrollment target is 531 participants, above the 49-participant average among 4 other Burnout, Healthcare Workers trials with a reported enrollment target (984% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05481138, a study of Burnout, Healthcare Workers, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 531 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to develop a technology to predict burnout in RNs by measuring workplace, psychological, and physiological factors experienced by nurses.
Primary Outcome
Self-reported Maslach Burnout Inventory-Human Services Survey (MBI-HSS) assess clinician well-being in dimensions of burnout, engagement, and professional satisfaction. 22-item questionnaire ranking job-related feeling on 0 to 6 scale; 0 = never had this feeling, 6 = every day had this feeling
Conditions Studied
Study Locations (2)
Florida
- Mayo Clinic in Florida - Jacksonville
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 531 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2025-03-01 |
What the finished NCT05481138 record still lists
NCT05481138 is an observational study that tracks outcomes without assigning an intervention. The registered 531 participants enrollment target is mid-sized for trials with a published cap, above the 49-participant average among 4 other Burnout, Healthcare Workers trials with a reported enrollment target (984% higher).
The record links to 1 condition, with Burnout, Healthcare Workers appearing as the primary indexed condition, and to 0 interventions.
NCT05481138 reports a single indexed study location in Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05481138 about?
NCT05481138 is a clinical study titled "Predicting Burnout in Nurses". The purpose of this study is to develop a technology to predict burnout in RNs by measuring workplace, psychological, and physiological factors experienced by nurses.
What is the current status of trial NCT05481138?
This trial is currently completed. The enrollment target is 531 participants. The study started on 2022-08-15. Estimated completion is 2025-03-01.
What conditions does trial NCT05481138 study?
This clinical trial studies the following conditions: Burnout, Healthcare Workers.
Who is sponsoring clinical trial NCT05481138?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05481138 being conducted?
This trial has 2 study locations across Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burnout, Healthcare Workers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Psilocybin-Assisted Therapy for Physician Well-Being and Burnout
RECRUITING · Phase 1
-
A Study Of Resilience And Mental Well-Being Through Breathing Practice For Clinical Care Professionals
RECRUITING · NA
-
The Counselor Led Resident Wellness Study
ACTIVE NOT RECRUITING · NA
-
RISE for Nurse Preceptors
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07219173 · 531 participants · Phase 2
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- NCT05793151 · 532 participants · NA
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
- NCT06378866 · 532 participants · Phase 2
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- NCT06646276 · 530 participants · Phase 3
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI